TY - JOUR
T1 - The Tetracycline Destructases
T2 - A Novel Family of Tetracycline-Inactivating Enzymes
AU - Forsberg, Kevin J.
AU - Patel, Sanket
AU - Wencewicz, Timothy A.
AU - Dantas, Gautam
N1 - Funding Information:
We thank J. Vogel for graciously sharing the L. longbeachae strain, B. Wang for contributions to Illumina library preparation that enabled discovery of these enzymes, S. Alvarez at the Proteomics & Mass Spectrometry Facility of the Danforth Plant Science Center for help quantifying tetracycline and with high-resolution tandem MS, the Genome Technology Access Center at Washington University School of Medicine for Illumina sequencing services, and members of the Wencewicz and Dantas labs for their help with protocol optimization and for thoughtful discussions on the results and analyses presented herein. Research reported in this publication was supported in part by grants to G.D. by the NIH Director's New Innovator Award ( http://commonfund.nih.gov/newinnovator/ ), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK: http://www.niddk.nih.gov/ ), and the National Institute of General Medical Sciences (NIGMS: http://www.nigms.nih.gov/ ), of the NIH under award numbers DP2DK098089 and R01GM099538, and the Children's Discovery Institute under award number MD-II-2011-117. T.A.W. was supported by start-up funds from Washington University in St. Louis. K.J.F. is a National Science Foundation graduate research fellow (award number DGE-1143954) and received support from training grants through the National Human Genome Research Institute (NHGRI: https://www.genome.gov/ ) and the NIGMS through award numbers T32HG000045 and T32GM007067. This material is based upon work supported by the National Science Foundation under Grant No. DBI-0922879 for acquisition of the LTQ-Velos Pro Orbitrap LC-MS/MS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.
Publisher Copyright:
© 2015 Elsevier Ltd.
PY - 2015/7/24
Y1 - 2015/7/24
N2 - Summary Enzymes capable of inactivating tetracycline are paradoxically rare compared with enzymes that inactivate other natural-product antibiotics. We describe a family of flavoenzymes, previously unrecognizable as resistance genes, which are capable of degrading tetracycline antibiotics. From soil functional metagenomic selections, we discovered nine genes that confer high-level tetracycline resistance by enzymatic inactivation. We also demonstrate that a tenth enzyme, an uncharacterized homolog in the human pathogen Legionella longbeachae, similarly inactivates tetracycline. These enzymes catalyze the oxidation of tetracyclines in vitro both by known mechanisms and via previously undescribed activity. Tetracycline-inactivation genes were identified in diverse soil types, encompass substantial sequence diversity, and are adjacent to genes implicated in horizontal gene transfer. Because tetracycline inactivation is scarcely observed in hospitals, these enzymes may fill an empty niche in pathogenic organisms, and should therefore be monitored for their dissemination potential into the clinic.
AB - Summary Enzymes capable of inactivating tetracycline are paradoxically rare compared with enzymes that inactivate other natural-product antibiotics. We describe a family of flavoenzymes, previously unrecognizable as resistance genes, which are capable of degrading tetracycline antibiotics. From soil functional metagenomic selections, we discovered nine genes that confer high-level tetracycline resistance by enzymatic inactivation. We also demonstrate that a tenth enzyme, an uncharacterized homolog in the human pathogen Legionella longbeachae, similarly inactivates tetracycline. These enzymes catalyze the oxidation of tetracyclines in vitro both by known mechanisms and via previously undescribed activity. Tetracycline-inactivation genes were identified in diverse soil types, encompass substantial sequence diversity, and are adjacent to genes implicated in horizontal gene transfer. Because tetracycline inactivation is scarcely observed in hospitals, these enzymes may fill an empty niche in pathogenic organisms, and should therefore be monitored for their dissemination potential into the clinic.
UR - http://www.scopus.com/inward/record.url?scp=84937712866&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937712866&partnerID=8YFLogxK
U2 - 10.1016/j.chembiol.2015.05.017
DO - 10.1016/j.chembiol.2015.05.017
M3 - Article
C2 - 26097034
AN - SCOPUS:84937712866
VL - 22
SP - 888
EP - 897
JO - Cell Chemical Biology
JF - Cell Chemical Biology
SN - 2451-9448
IS - 7
M1 - 3070
ER -